Baylor announces plans for $350 million North Texas cancer hospital
Baylor Health Care System on Thursday announced plans for a Baylor Cancer Center, calling it the first dedicated cancer hospital in North Texas.
Seattle-based Grid Computing Vendor Expands Product Line to Include In
Continued support for the OS X platform results in substantial performances increases of the JIVA Grid Computing Client on the Intel Core Duo. Considerable benefit expected for applications in bioinformatics, pharmaceuticals, energy, financial analysis, engineering, and animation (PRWEB May 19, 2006)Trackback URL: http://www.prweb.com/chachingpr.php/SGFsZi1TdW1tLUluc2UtQ3Jhcy1IYWxmLVplcm8=
BreastCancerSurvivalMayRuninFamilies
Title: BreastCancerSurvivalMayRuninFamilies
Category: Health News
Created: 6/29/2007 2:00:00 AM
Last Editorial Review: 6/29/2007
PreventBreastCancerNow.com Moves Breast Cancer Awareness Discussion to
Dr. Lynn Fraley reveals unpublicized findings. (PRWeb Oct 31, 2007)Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/TG92ZS1NYWduLUNvdXAtWmV0YS1UaGlyLVplcm8=
Global Melanoma Therapeutics Market to Reach $1.1 Billion by 2015, Acc
GIA announces the release of a comprehensive global report on melanoma therapeutics markets. The world market for melanoma therapeutics is projected to reach $1.1 billion by 2015. This is primarily driven by rapid rise in the number of people suffering from melanoma of skin, due to increased exposure to UV rays and depletion of ozone layer. Additionally, R&D initiatives to discover and develop new treatment options will contribute to market growth. (PRWeb Mar 31, 2010)
Read the full story at http://www.prweb.com/releases/melanoma_therapeutics/dacarbazine/prweb3801474.htm
QC Sciences™Announces Innovative Solution to Reduce Laboratory Costs
QC Sciences, a manufacturer and distributor of innovative, cost-effective medical devices, announces immediate availability of an economical liquid-based cytology system. The NuView System For Non-Gyn Cytology is designed to bring affordable cytology to any size laboratory. (PRWeb Nov 18, 2008)
Read the full story at http://www.prweb.com/releases/qc_sciences/nuview_system/prweb1634174.htm
ResearchersLaunchBreastCancerPreventionDrugTrial
Title: ResearchersLaunchBreastCancerPreventionDrugTrial
Category: Health News
Created: 4/1/05 1:59:00 AM
Last Editorial Review: 4/1/05 1:58:39 AM
Heart-attack survivor is up and running again
Weldon Reed was a quarter-mile into last year's Race for the Cure 5K when, in his words, he dropped dead on the pavement.
Mesocare.org Presents Question and Answer Session for Mesothelioma Pat
On Tuesday February 9, 2010 at 5:00 pm CST, Sharon Myers, Nurse Practitioner of MD Anderson will be taking calls and e-mails on behalf of Mesocare.org for patients and their families. (PRWeb Feb 8, 2010)
Read the full story at http://www.prweb.com/releases/2010/02/prweb3576714.htm
New drug shrinks prostate tumors
An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday.
